SecSonar.com

Neuronetics, Inc. (STIM)

Neuronetics, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Neuronetics, Inc. (STIM) is a Medical - Diagnostics & Research company based in US with a market capitalization of $104.4M. Revenue grew 99.2% year-over-year and free cash flow was negative at -$21.2M. This page tracks STIM's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 716 employees · IPO Jun 28, 2018

Valuation

Valuation & price

$1.28 · as of May 17, 2026 · -72.5% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

4.66

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$4.66$2.92$1.18Jul 25Dec 25Jul 26Jul 7, 25$3.37Jul 9, 25$3.50Jul 11, 25$3.57Jul 15, 25$3.74Jul 17, 25$3.83Jul 21, 25$3.88Jul 23, 25$4.44Jul 25, 25$4.49Jul 29, 25$4.47Jul 31, 25$4.39Aug 4, 25$4.66Aug 6, 25$4.25Aug 11, 25$3.92Aug 13, 25$3.87Aug 15, 25$3.34Aug 19, 25$3.37Aug 21, 25$3.38Aug 25, 25$3.20Aug 27, 25$3.36Aug 29, 25$3.33Sep 3, 25$3.27Sep 5, 25$3.23Sep 9, 25$3.69Sep 11, 25$3.46Sep 16, 25$2.77Sep 18, 25$2.91Sep 22, 25$2.84Sep 24, 25$2.79Sep 26, 25$2.71Sep 30, 25$2.73Oct 2, 25$2.67Oct 6, 25$2.83Oct 8, 25$2.97Oct 10, 25$2.79Oct 14, 25$2.89Oct 16, 25$2.88Oct 21, 25$2.88Oct 23, 25$2.96Oct 27, 25$3.09Oct 29, 25$2.90Oct 31, 25$2.65Nov 4, 25$2.87Nov 6, 25$2.52Nov 10, 25$2.14Nov 12, 25$2.16Nov 14, 25$1.99Nov 18, 25$1.50Nov 20, 25$1.30Nov 25, 25$1.37Nov 28, 25$1.49Dec 2, 25$1.32Dec 4, 25$1.45Dec 8, 25$1.30Dec 10, 25$1.33Dec 12, 25$1.52Dec 16, 25$1.65Dec 18, 25$1.42Dec 22, 25$1.54Dec 24, 25$1.42Dec 29, 25$1.38Jan 2, 26$1.44Jan 6, 26$1.69Jan 8, 26$1.96Jan 12, 26$1.98Jan 14, 26$1.77Jan 16, 26$1.90Jan 21, 26$1.99Jan 23, 26$2.13Jan 27, 26$2.24Jan 29, 26$2.20Feb 2, 26$1.99Feb 4, 26$1.55Feb 9, 26$1.49Feb 11, 26$1.80Feb 13, 26$1.42Feb 18, 26$1.38Feb 20, 26$1.29Feb 24, 26$1.27Feb 26, 26$1.42Mar 2, 26$1.29Mar 4, 26$1.33Mar 6, 26$1.38Mar 10, 26$1.22Mar 12, 26$1.27Mar 17, 26$1.23Mar 19, 26$1.52Mar 23, 26$1.60Mar 25, 26$1.40Mar 27, 26$1.29Mar 31, 26$1.45Apr 2, 26$1.52Apr 7, 26$1.58Apr 9, 26$1.38Apr 13, 26$1.39Apr 15, 26$1.39Apr 17, 26$1.42Apr 22, 26$1.59Apr 24, 26$1.68Apr 28, 26$1.64Apr 30, 26$1.94May 4, 26$2.02May 6, 26$1.91May 8, 26$1.66May 12, 26$1.27May 14, 26$1.30May 18, 26$1.18May 20, 26$1.19May 22, 26$1.20May 28, 26$1.54Jun 1, 26$1.67Jun 3, 26$1.39Jun 5, 26$1.29Jun 9, 26$1.24Jun 11, 26$1.31Jun 15, 26$1.27Jun 17, 26$1.21Jun 22, 26$1.20Jun 24, 26$1.26Jun 26, 26$1.34Jul 2, 26$1.41
$1.1852-week range$4.66
Loading valuation history…

Fundamentals

Key fundamentals

$104.4M

Market cap

99.2%

Revenue growth (YoY)

48.5%

Gross margin

-$21.2M

Free cash flow (USD)

$55.9M

Net debt

107.8%

Share dilution

0/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$34.2MFY 2017$40.4MFY 2018$52.8MFY 2019$62.7MFY 2020$49.2MFY 2021$55.3MFY 2022$65.2MFY 2023$71.3MFY 2024$74.9MFY 2025$149.2M
$34.2M$149.2M

Free cash flow by year

2016 → 2025

FY 2016$-8.9MFY 2017$-11.7MFY 2018$-21.6MFY 2019$-31.3MFY 2020$-29.1MFY 2021$-30.3MFY 2022$-34.0MFY 2023$-34.4MFY 2024$-32.5MFY 2025$-21.2M
-$8.9M-$21.2M

Gross margin by year

2021 → 2025

FY 202178.9%FY 202276.3%FY 202372.5%FY 202472.3%FY 202548.5%
78.9%48.5%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

3

Insider buys · 90 days

1

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 5, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventExecutive PromotionJun 23, 2026Filing
  • 8-K eventAnnual Meeting ResultsMay 29, 2026Filing
  • 8-K eventConsulting Agreement AmendedMay 22, 2026Filing
  • Insider sellInsider Sell $11KPfanstiel Steven · Former EVP, CFO and Treasurer · $11.5KMay 21, 2026Filing
  • Insider buyInsider Buy $117KChernett Jorey · 10% Owner · $117KMay 20, 2026Filing
  • Insider buyInsider Buy $636KChernett Jorey · 10% Owner · $636.5KMay 13, 2026Filing
  • 8-K eventEarnings ReleaseMay 5, 2026Filing
  • Quarterly report10-Q FiledMay 5, 2026Filing
  • Insider buyInsider Buy $309KChernett Jorey · 10% Owner · $309KApr 22, 2026Filing
  • 8-K eventConsulting Agreement ExecutedApr 6, 2026Filing

Questions

Frequently asked questions

What is Neuronetics, Inc.'s market cap?

Neuronetics, Inc. (STIM) has a market capitalization of $104.4M.

What is STIM's P/E ratio?

A meaningful P/E ratio is not available for STIM — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is STIM's price-to-book (P/B) ratio?

STIM trades at 4.66 times book value per share.

Are insiders buying STIM stock?

Yes — SEC Form 4 filings show 3 open-market insider buys and 1 sell at Neuronetics, Inc. in the last 90 days.

Same arena

Related companies in Medical - Diagnostics & Research

XGN

Exagen Inc.

$119.6M

ATLN

Atlantic International Corp.

$122.2M

SERA

Sera Prognostics, Inc.

$85.5M

BDSX

Biodesix, Inc.

$129.6M

DRIO

DarioHealth Corp.

$55.2M

STRR

Star Equity Holdings, Inc.

$42.6M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.